These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30905286)

  • 1. Genome-wide correlation analysis suggests different roles of CRISPR-Cas systems in the acquisition of antibiotic resistance genes in diverse species.
    Shehreen S; Chyou TY; Fineran PC; Brown CM
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180384. PubMed ID: 30905286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas is associated with fewer antibiotic resistance genes in bacterial pathogens.
    Pursey E; Dimitriu T; Paganelli FL; Westra ER; van Houte S
    Philos Trans R Soc Lond B Biol Sci; 2022 Jan; 377(1842):20200464. PubMed ID: 34839714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa.
    van Belkum A; Soriaga LB; LaFave MC; Akella S; Veyrieras JB; Barbu EM; Shortridge D; Blanc B; Hannum G; Zambardi G; Miller K; Enright MC; Mugnier N; Brami D; Schicklin S; Felderman M; Schwartz AS; Richardson TH; Peterson TC; Hubby B; Cady KC
    mBio; 2015 Nov; 6(6):e01796-15. PubMed ID: 26604259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa.
    Pawluk A; Bondy-Denomy J; Cheung VH; Maxwell KL; Davidson AR
    mBio; 2014 Apr; 5(2):e00896. PubMed ID: 24736222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas system, antibiotic resistance and virulence in bacteria: Through a common lens.
    Roy S; Naha S; Rao A; Basu S
    Prog Mol Biol Transl Sci; 2021; 178():123-174. PubMed ID: 33685595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel PCR detection of CRISPR/Cas systems in Pseudomonas aeruginosa and its correlation with antibiotic resistance.
    Soliman M; Said HS; El-Mowafy M; Barwa R
    Appl Microbiol Biotechnol; 2022 Nov; 106(21):7223-7234. PubMed ID: 36178514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.
    Saha U; Gondi R; Patil A; Saroj SD
    Mol Biotechnol; 2023 Jan; 65(1):1-16. PubMed ID: 35939207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance.
    Kadkhoda H; Gholizadeh P; Samadi Kafil H; Ghotaslou R; Pirzadeh T; Ahangarzadeh Rezaee M; Nabizadeh E; Feizi H; Aghazadeh M
    Heliyon; 2024 Jul; 10(14):e34692. PubMed ID: 39149034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas system: a potential alternative tool to cope antibiotic resistance.
    Aslam B; Rasool M; Idris A; Muzammil S; Alvi RF; Khurshid M; Rasool MH; Zhang D; Ma Z; Baloch Z
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):131. PubMed ID: 32778162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why put up with immunity when there is resistance: an excursion into the population and evolutionary dynamics of restriction-modification and CRISPR-Cas.
    Gurney J; Pleška M; Levin BR
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180096. PubMed ID: 30905282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species.
    Pawluk A; Staals RH; Taylor C; Watson BN; Saha S; Fineran PC; Maxwell KL; Davidson AR
    Nat Microbiol; 2016 Jun; 1(8):16085. PubMed ID: 27573108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriostatic antibiotics promote CRISPR-Cas adaptive immunity by enabling increased spacer acquisition.
    Dimitriu T; Kurilovich E; Łapińska U; Severinov K; Pagliara S; Szczelkun MD; Westra ER
    Cell Host Microbe; 2022 Jan; 30(1):31-40.e5. PubMed ID: 34932986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of bacterial mutation rate on the evolution of CRISPR-Cas adaptive immunity.
    Chevallereau A; Meaden S; van Houte S; Westra ER; Rollie C
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180094. PubMed ID: 30905293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Interplay of the CRISPR-CAS System with Antibiotic Resistance in
    Shabbir MAB; Ul-Rahman A; Iftikhar MR; Rasheed M; Maan MK; Sattar A; Ahmad M; Khan FA; Ahmad W; Riaz MI; Aslam HB
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256391
    [No Abstract]   [Full Text] [Related]  

  • 15. Degradation of Antibiotic Resistance Genes by VADER with CRISPR-Cas Immunity.
    Li X; Bao N; Yan Z; Yuan XZ; Wang SG; Xia PF
    Appl Environ Microbiol; 2023 Apr; 89(4):e0005323. PubMed ID: 36975789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fitness costs of CRISPR-Cas systems in bacteria.
    Zaayman M; Wheatley RM
    Microbiology (Reading); 2022 Jul; 168(7):. PubMed ID: 35849532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogenomics of Cas4 family nucleases.
    Hudaiberdiev S; Shmakov S; Wolf YI; Terns MP; Makarova KS; Koonin EV
    BMC Evol Biol; 2017 Nov; 17(1):232. PubMed ID: 29179671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas and Restriction-Modification Act Additively against Conjugative Antibiotic Resistance Plasmid Transfer in Enterococcus faecalis.
    Price VJ; Huo W; Sharifi A; Palmer KL
    mSphere; 2016; 1(3):. PubMed ID: 27303749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous
    Wang Y; Yang J; Sun X; Li M; Zhang P; Zhu Z; Jiao H; Guo T; Li G
    Microbiol Spectr; 2022 Aug; 10(4):e0082922. PubMed ID: 35938813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origins and evolution of CRISPR-Cas systems.
    Koonin EV; Makarova KS
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180087. PubMed ID: 30905284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.